Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

O'Malley S et al. - Decreased activity of Erk2, AKT, CrkL, PDK1, and Smads were observed in TOB-overexpressing cells. Taken together, these data provide evidence that TOB can function as a tumor suppressor in breast cancer through modulation and regulation of multiple signaling pathways.

Related Articles

Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis
Cancer Research, 11/17/09    Relevance Score: 81%

The Expression and Function of IGFBP-3 in Normal and Malignant Breast Tissue
Anticancer Research, 11/10/09    Relevance Score: 81%

Regulation of Clusterin Expression in Human Cancer via DNA Methylation
Tumor Biology, 11/25/09    Relevance Score: 78%

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09    Relevance Score: 74%

Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09    Relevance Score: 72%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address